FDA, NCI, AACR, ASCO, Duke Comprehensive Cancer Center
Accelerating Anticancer Agent Development and Validation Workshop (Clinical Development)
2010 - 2010
Albert Einstein College of Medicine
Postdoctoral Research Associate (Cancer Genetics)
2000 - 2005
National University of Singapore
Ph.D. (Molecular Oncology)
1996 - 2000
Tianjin Medical University
M.D. (Nankai University and Tianjin Medical University 8-Year Program) (Clinical Medicine)
1989 - 1994
Nankai University
Premed (Nankai University and Tianjian Medical University 8-Year Program) (Premed)
1986 - 1989
Yuxun Wang's Skills
Drug Discovery
Lifesciences
Oncology
Clinical Development
CRO
Pharmacology
Animal Models
In Vivo
In Vitro
Genetics
Yuxun Wang's Summary
Yuxun Wang, based in Boston, MA, US, is currently a Chief Executive Officer at APS, Inc., bringing experience from previous roles at Pharscin Pharma, Denovo Pharmatech and WuXi AppTec. Yuxun Wang holds a 2019 - 2019 ICH GCP Certificate in Clinical Development @ ICON Firecrest. With a robust skill set that includes Drug Discovery, Lifesciences, Oncology, Clinical Development, CRO and more, Yuxun Wang contributes valuable insights to the industry. Yuxun Wang has 1 email and 1 mobile phone number on RocketReach.